Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL
2025 · Transplantation and Cellular Therapy · 1 citations
https://doi.org/10.1016/j.jtct.2025.01.882
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
28
Citations
3
h-index
1
i10-index
Shohei Tomori is an academic researcher from Children's Medical Center. The author has contributed to research in topics: T-cell and Retrovirus Studies & Viral-associated cancers and disorders & Vector-Borne Animal Diseases. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat